|
|||||
|
|
Reversible thrombotic aortic valve restenosis after valve‐in‐valve transcatheter aortic valve replacement |
|
| Authors: | Patrick J Goleski MD Mark Reisman MD Creighton W Don MD |
| Institution: | University of Washington, Division of Cardiology, Box 356422, Seattle, WA 98195‐6422 |
| Abstract: | Thrombotic aortic valve restenosis following transcatheter aortic valve replacement (TAVR) has not been extensively reported and the rates of TAVR valve thrombosis are not known. We present three cases of valve‐in‐valve (VIV) restenosis following TAVR with the balloon expandable transcatheter heart valves, presumably due to valve thrombosis that improved with anticoagulation. © 2016 Wiley Periodicals, Inc. |
| Keywords: | aortic valve disease percutaneous intervention structural heart disease intervention transcatheter valve implantation anticoagulants/antithrombins antiplatelet therapy percutaneous valve therapy |